Choose topics to filter the report

Your filter results

Consolidated statement of cash flows

(In € million)

 

Note

 

Year ended
31 Dec. 2022

 

Year ended
31 Dec. 2021

Cash flows from operating activities

 

 

 

 

 

 

Profit for the period

 

 

 

37.8

 

172.1

Adjustments for:

 

 

 

 

 

 

Depreciation and amortisation

 

12, 13, 14

 

366.7

 

306.6

Impairment losses

 

12

 

6.3

 

4.4

Net change in fair value of operating derivatives

 

 

 

39.5

 

(7.4)

Realised gain on settlement of deal-contingent derivatives

 

27

 

(16.6)

 

Share-based payment expense

 

31

 

5.4

 

3.8

Gain on sale of property, plant and equipment and non-current assets

 

 

 

(0.5)

 

(0.8)

Loss on sale of subsidiary

 

26

 

 

12.1

Gain on pre-existing interest in former joint ventures

 

27

 

 

(48.8)

Share of loss of joint ventures

 

28

 

 

1.6

Net finance expense

 

23

 

26.0

 

31.4

Interest paid

 

 

 

(52.2)

 

(40.6)

Payment of transaction and other costs relating to financing

 

22

 

(3.3)

 

Income tax expense

 

32

 

51.0

 

52.3

Income taxes paid, net of refunds received

 

 

 

(94.4)

 

(73.0)

 

 

 

 

365.7

 

413.7

Change in trade and other receivables

 

 

 

(34.0)

 

(4.0)

Change in inventories

 

 

 

(53.1)

 

(9.4)

Change in trade and other payables

 

 

 

234.3

 

62.5

Change in provisions and employee benefits

 

 

 

(14.4)

 

14.9

Change in other assets and liabilities

 

 

 

79.7

 

53.2

Net cash from operating activities

 

11

 

578.2

 

530.9

Cash flows from investing activities

 

 

 

 

 

 

Acquisition of businesses, net of cash acquired

 

27

 

(700.4)

 

(63.6)

Settlement of deal-contingent derivatives

 

27

 

61.1

 

Sale of subsidiary, net of cash disposed of

 

26

 

 

3.1

Acquisition of property, plant and equipment and intangible assets

 

12, 14

 

(299.7)

 

(245.9)

Proceeds from sale of property, plant and equipment and other assets

 

27

 

19.1

 

1.1

Proceeds from sale of securities

 

 

 

0.4

 

Interest received

 

 

 

1.6

 

1.5

Net cash used in investing activities

 

11

 

(917.9)

 

(303.8)

Cash flows from financing activities

 

 

 

 

 

 

Proceeds from issue of shares

 

24

 

203.5

 

Payment of costs for placement of shares

 

24

 

(3.6)

 

Proceeds from loans and borrowings

 

22

 

1,710.0

 

100.0

Repayment of loans and borrowings

 

22

 

(1,189.0)

 

(239.5)

Settlement of deal-contingent derivative

 

27

 

15.5

 

Payment of lease liabilities

 

22

 

(34.5)

 

(26.7)

Purchase of treasury shares

 

24

 

(16.3)

 

(0.7)

Payment of dividends

 

24

 

(147.9)

 

(128.1)

Other

 

 

 

1.1

 

1.4

Net cash from/(used in) financing activities

 

11

 

538.8

 

(293.6)

Net increase/(decrease) in cash and cash equivalents

 

 

 

199.1

 

(66.5)

Cash and cash equivalents as of the beginning of the period

 

 

 

304.5

 

355.1

Effect of exchange rate fluctuations on cash and cash equivalents

 

 

 

0.2

 

15.9

Cash and cash equivalents as of the end of the period

 

17

 

503.8

 

304.5

Share this page